文献速递造血干细胞移植与细胞治疗

造血干细胞移植支持治疗干预:系统综述与荟萃分析

Supportive care interventions in hematopoietic stem cell transplantation: a systematic review and meta-analysis.
PubMed 文献 · Blood Adv · 2026-01-01

干预类型共9类,多数可行且可接受,在心理困扰、生活质量和躯体结局方面有改善趋势。荟萃分析显示运动干预改善生活质量和音乐/艺术干预减轻急性抑郁症状均呈非显著趋势。

要点

  • 支持治疗干预在HSCT患者中可行且可接受,对心理困扰、生活质量和躯体结局有改善前景。
  • 运动干预改善生活质量(SMD 0.09)和音乐/艺术干预减轻急性抑郁症状(SMD -0.26)均为非显著趋势。
  • 现有RCT样本量(11-711)和PROs异质性大,需更大规模、标准化PRO测量的严谨RCT确立疗效。

核心结论

  • 在因血液恶性肿瘤接受HSCT的患者中,支持治疗干预显示出可行性、可接受性及改善PROs的前景。
  • 需要更大规模、设计严谨且使用标准化PRO测量工具的RCT来确立疗效。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Embase、CINAHL、PsycInfo、Web of Science和Cochrane Central Register of Controlled Trials。
  • 使用Cochrane Risk of Bias 2.0评估偏倚风险,按干预和PRO类型分组叙述性综合,并对焦虑、抑郁和生活质量进行探索性随机效应荟萃分析。

主要发现

  • 共9类干预:认知行为(n=5)、仅运动(n=17)、表达性帮助(n=2)、身心/压力管理(n=7)、多模式(运动加另一模式,n=6)、音乐/艺术(n=12)、姑息治疗(n=2)、积极心理学(n=1)、自我管理/自我效能(n=5)。
  • 干预大多可行且可接受,在心理困扰、生活质量和躯体结局方面有改善前景。
  • 荟萃分析显示运动干预改善生活质量呈非显著趋势(SMD 0.09)。
  • 荟萃分析显示音乐/艺术干预减轻急性抑郁症状呈非显著趋势(SMD -0.26)。

关键数值与推荐

  • 运动干预改善生活质量的合并效应量SMD为0.09(非显著趋势)。
  • 音乐/艺术干预减轻急性抑郁症状的合并效应量SMD为-0.26(非显著趋势)。

临床怎么用

  • 支持治疗干预可考虑用于HSCT患者以改善心理困扰、生活质量和躯体结局,但当前证据尚未确立确切疗效。
  • 运动干预和音乐/艺术干预分别对生活质量和急性抑郁症状有改善趋势,可作为临床选择参考。

局限性

  • 检索仅获得HSCT受者的RCT,尽管研究旨在纳入所有移植与细胞治疗。
  • 研究样本量(11-711)、人口学特征和PROs存在异质性。
  • 荟萃分析为探索性,运动和生活质量及音乐/艺术和抑郁的效应均未达统计学显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is no comprehensive synthesis of supportive care interventions for patients with hematologic malignancies receiving transplantation and cellular therapies (TCTs). This systematic review and meta-analysis aimed to characterize randomized controlled trials (RCTs) of TCT supportive care interventions and examine effects on patient-reported outcomes (PROs). We systematically searched MEDLINE, Embase, CINAHL, PsycInfo, Web of Science, and Cochrane Central Register of Controlled Trials. Risk of bias was assessed using Cochrane Risk of Bias 2.0. Findings were grouped by intervention and PRO type and synthesized narratively, with exploratory random-effects meta-analyses estimating pooled intervention effects on anxiety, depression, and quality of life (QOL). Fifty-three RCTs (1992-2025) met inclusion criteria. The search yielded only RCTs of hematopoietic stem cell transplantation (HSCT) recipients, although we included all transplantation and cellular therapies. Studies varied in sample size (11-711), participant demographics (mean age, 33-63 years; 22%-64% women), and PROs. There were 9 intervention categories: cognitive behavioral (n = 5), exercise only (n = 17), expressive helping (n = 2), mind-body/stress management (n = 7), multimodal (exercise plus another modality; n = 6), music/art (n = 12), palliative care (n = 2), positive psychology (n = 1), and self-management/self-efficacy (n = 5). Interventions were mostly feasible and acceptable, with promising improvements in psychological distress, QOL, and physical outcomes. Meta-analysis showed nonsignificant trends toward exercise interventions improving QOL (standardized mean differences [SMD], 0.09) and music/art interventions reducing acute depressive symptoms (SMD, -0.26). Among patients undergoing HSCT for hematologic malignancies, supportive care interventions show feasibility, acceptability, and promise for improving PROs. However, larger, rigorously designed RCTs using standardized PRO measures are needed to establish efficacy.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Schaefer DA, Guo M, Keane EP, et al. Supportive care interventions in hematopoietic stem cell transplantation: a systematic review and meta-analysis. Blood Adv. 2026. PMID: 41925563. doi:10.1182/bloodadvances.2026019724

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。